Showing results (11-20 of 600) with videos related to

Sort By:
Pageof 60
Upsala Journal of Medical Sciences|January 1, 1987
Treatment with clodronate in patients with hypercalcemia secondary to malignancyL Lind, B Wengle, S Ljunghall
Experimental and Clinical Endocrinology|September 1, 1990
Indices of mineral metabolism in subjects with an impaired glucose toleranceL Lind, H Lithell, A Hvarfner, et al.
American Journal of Hypertension|January 1, 1989
Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled studyL Lind, B Wengle, L Wide, et al.
Upsala Journal of Medical Sciences|January 1, 1991
No major metabolic alterations accompany the hypotensive effect of active vitamin DL Lind, B Wengle, H Lithell, et al.
Acta Diabetologica|April 1, 1994
On the interplay between insulin secretion and sensitivity as determinants of glucose toleranceL Lind, H Lithell, T Pollare, et al.
Journal of Human Hypertension|February 1, 1992
Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertensionL Lind, H Lithell, L Wide, et al.
Journal of Internal Medicine|April 1, 1992
Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long-term treatment with active vitamin D (alphacalcidol)L Lind, B Wengle, H Lithell, et al.
Experimental and Clinical Endocrinology|January 1, 1993
On the diversity of insulin secretion and sensitivity in subjects with impaired glucose toleranceL Lind, H Lithell, P Pollare, et al.
American Journal of Hypertension|August 1, 1991
Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressureL Lind, H Lithell, T Pollare, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1991
Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individualsL Lind, B Wengle, H Lithell, et al.
Pageof 60